A new study has confirmed the accuracy of the Xpresys Lung 2 test developed by Integrated Diagnostics.
News & Features
Corindus Vascular tops revenue expectations for the fourth quarter of 2017 and gears up for tele-stenting trial with Mayo Clinic.
Texas A&M is launching a new engineering-based medical degree program in partnership with Houston Methodist Hospital that will educate a new kind of doctor with an engineering mindset.
Growth in biomaterials, drug and biologic combination devices, flexible sensors, electronics, and artificial intelligence, along with the manufacturing evolution of fast prototyping, 3D printing, and multiple additive and subtractive manufacturing, are driving interest in new materials.
These eight medtech startups are facing off to see which has what it takes to make it in the industry. Vote for your favorite!
The SEC charged Theranos, its founder and CEO Elizabeth Holmes, and its former president Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about the company's technology, business, and financial performance.
Qiagen, known for its oncology offerings, is set to develop assays for the non-invasive prenatal testing market through a $40 million collaboration with Natera.
An expert in quality management systems discusses FDA's Case for Quality pilot program and how it can save companies time and money.
FDA gave the company the green light to end a trial of its LAP-BAND System early, saving the company more than $5 million.
Medtronic continued to strengthen its TAVR story with 5-year-data recently presented at ACC18. The company is battling it out with Edwards in the U.S. market, while Boston Scientific seeks to find footing after delaying commercialization of the Lotus Edge valve.
An expert in the field of medical virtual reality technology gave SXSW attendees a taste of how VR is currently being used in healthcare, and where he sees VR medical technology going in the future.
After suffering a spinal cord injury eight years ago, doctors told Paul Campbell there was only a 3% chance he would ever walk again, Campbell said after walking across a room at SXSW with the assistance of the Phoenix exoskeleton from suitX.
Laborie Medical Technologies is poised to get a leg up in the urology market by acquiring Cogentix Medical for about $239 million.